Trial Profile
Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Pancreatic Cancer
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 May 2018
At a glance
- Drugs Anti CD3 MUC1 bispecific antibody Benhealth Biopharmaceutical (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 02 May 2018 New trial record